Cowen Upgrades Merrimack Pharmaceuticals (MACK) to Outperform
Tweet
Share
E-mailGet Alerts MACK Hot Sheet
Price: $15.13 --0%
Rating Summary:
5 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
5 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cowen upgraded Merrimack Pharmaceuticals (NASDAQ: MACK) from Market Perform to Outperform.
For an analyst ratings summary and ratings history on Merrimack Pharmaceuticals click here. For more ratings news on Merrimack Pharmaceuticals click here.
Shares of Merrimack Pharmaceuticals closed at $4.39 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New Street Research Upgrades Micron Technology (MU) to Buy
- Johnson Rice Upgrades Core Laboratories (CLB) to Buy
- JPMorgan Upgrades KCE Electronics PCL (KCE:TB) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
